May 19, 2025
11:00 AM ET
The offices of Willkie Farr & Gallagher LLP,
787 Seventh Avenue, New York, New York 10019
Innoviva is a diversified holding company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (GSK), as well as a growing portfolio of innovative healthcare investments and assets in areas of significant unmet medical need. We believe in the power of scientific innovation to make the world a better place and the value of thoughtful, strategic, well-capitalized partners, such as ourselves, to make what’s possible a reality.